Publicaciones en colaboración con investigadores/as de University of Montpellier (11)

2024

  1. Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM

    Intensive Care Medicine

2023

  1. WAO consensus on DEfinition of Food Allergy SEverity (DEFASE)

    World Allergy Organization Journal, Vol. 16, Núm. 3

2022

  1. Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 40, Núm. 12, pp. 1301-1311

  2. Potent Neutralizing Activity of Polyclonal Equine Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern

    The Journal of infectious diseases, Vol. 227, Núm. 1, pp. 35-39

2021

  1. Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis

    Scientific Reports, Vol. 11, Núm. 1

  2. Management of anaphylaxis due to COVID-19 vaccines in the elderly

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 10, pp. 2952-2964

2020

  1. Evolving the comprehensive management of rheumatoid arthritis: identification of unmet needs and development of practical and educational tools

    Clinical and experimental rheumatology, Vol. 38, Núm. 6, pp. 1056-1067

  2. Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers

    Blood, Vol. 136, Núm. 6, pp. 698-714

2019

  1. Epidemiology of intra-abdominal infection and sepsis in critically ill patients: “AbSeS”, a multinational observational cohort study and ESICM Trials Group Project

    Intensive Care Medicine, Vol. 45, Núm. 12, pp. 1703-1717

2017

  1. 2016 update of the EULAR recommendations for the management of early arthritis

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 6, pp. 948-959

2016

  1. Prediction of remission in a French early arthritis cohort by RAPID3 and other core data set measures, but not by the absence of rheumatoid factor, anticitrullinated protein antibodies, or radiographic erosions

    Journal of Rheumatology, Vol. 43, Núm. 7, pp. 1285-1291